Fulcrum Therapeutics Inc (FULC)
Cost of Revenue
$216.00K
Quarterly · Period ending: · USD
FULC Cost of Revenue
Latest reported$216.00Kperiod ending
Latest reported$216.00Kperiod ending
FULC Quarterly Cost of Revenue ($0.00 → $216.00K)
Quarterly cost of revenue
High-resolution chart · PNG
FULC cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 216,000 | |
| 338,000 | |
| -300,000 | |
| 14,296,000 | |
| 300,000 | |
| 13,404,000 | |
| 369,000 | |
| 14,639,000 | |
| 17,261,000 | |
| 479,000 | |
| 508,000 | |
| 18,238,000 | |
| 17,849,000 | |
| 16,715,000 | |
| 18,566,000 | |
| 15,366,000 | |
| 25,019,000 | |
| 17,831,000 | |
| 18,912,000 | |
| 17,077,000 | |
| 17,378,000 | |
| 16,334,000 | |
| 16,145,000 | |
| 15,640,000 | |
| 12,775,000 | |
| 14,482,000 | |
| 519,000 | |
| 13,496,000 | |
| 10,860,000 | |
| 34,629,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |